85631-006-01-gout Relief 3310-s-new

85631-006-01-gout Relief 3310-s-new
SPL v1
SPL
SPL Set ID 3dbf3436-16b9-b793-e063-6394a90a1e71
Route
ORAL
Published
Effective Date 2025-09-01
Document Type 34390-5 HUMAN OTC DRUG LABEL

Drug Facts

Composition & Product

Active Ingredients
Coix Lacryma-jobi Seed (104 mg) Medicago Sativa Whole (260 mg) Buckwheat (91 mg) Tea Leaf (65 mg) Morus Alba Leaf (169 mg) Chicory Root (299 mg) Fu Ling (26 mg) Glucosamine (130 mg) Licorice (2.6 mg)
Inactive Ingredients
Maltosyl-isomaltotetraose Sodium Chloride Magnesium Stearate Microcrystalline Cellulose Carboxymethylcellulose Sodium

Identifiers & Packaging

Pill Appearance
Shape: capsule Color: white Size: 20 mm
Marketing Status
UNAPPROVED HOMEOPATHIC Active Since 2025-09-01

Description

MEDICAGO SATIVA WHOLE 20.00% CHICORY ROOT 23.00% GLUCOSAMINE HYDROCHLORIDE 10.00% BUCKWHEAT 7.00% TEA LEAF 5.00% MORUS ALBA LEAF 13.00% LICORICE 0.20% FU LING 2.00% COIX LACRYMA-JOBI SEED 8.00%


Medication Information

Warnings and Precautions

For your health, please read the followingcarefully

1. The use of three vials can effectivety dissolve crystallization (ittakes time to dissolve crystallization);2. The product has great somatosensation after taking it atleast 21 days in the early stage;3. Elevated uric acid or gout recurrence and site changes arenormal in the early stage of taking this product;4. Try not to drink alcohol or drink less 15 days before takingthis product;

5. This product certainly has significant effect on gout,crystallization and hyperuricemia;

Indications and Usage

Dissolved CrystallizationKidney StoneGallstone< Urinary Calculus

Dosage and Administration

The product has great somatosensation after taking it atleast 21 days in the earty stage;3. Elevated uric acid or gout recurrence and site changes arenoral in the earty stage of taking this product;

Description

MEDICAGO SATIVA WHOLE 20.00% CHICORY ROOT 23.00% GLUCOSAMINE HYDROCHLORIDE 10.00% BUCKWHEAT 7.00% TEA LEAF 5.00% MORUS ALBA LEAF 13.00% LICORICE 0.20% FU LING 2.00% COIX LACRYMA-JOBI SEED 8.00%

Section 50565-1

Keep out of reach of children

Section 51727-6

This product has a significanteffect on gout, crystal deposits,and hyperuricemia;

elt has an auxiliary effectof mitigating kidney stonesand bladder stones

Section 51945-4

Section 55105-1

This product has a significanteffect on gout, crystal deposits,and hyperuricemia; elt has an auxiliary effectof mitigating kidney stonesand bladder stones

Section 55106-9

MEDICAGO SATIVA WHOLE 20.00%

CHICORY ROOT 23.00%

GLUCOSAMINE HYDROCHLORIDE 10.00%

BUCKWHEAT 7.00%

TEA LEAF 5.00%

MORUS ALBA LEAF 13.00%

LICORICE 0.20%

FU LING 2.00%

COIX LACRYMA-JOBI SEED 8.00%

Section 60561-8

Do not use if seal is broken.

Do not eat freshness packet enclosed.

Keep out of direct sunlight, high temperature, and humidity.

Store in a cool, dry place.


Structured Label Content

Indications and Usage (34067-9)

Dissolved CrystallizationKidney StoneGallstone< Urinary Calculus

Dosage and Administration (34068-7)

The product has great somatosensation after taking it atleast 21 days in the earty stage;3. Elevated uric acid or gout recurrence and site changes arenoral in the earty stage of taking this product;

Warnings and Precautions (34071-1)

For your health, please read the followingcarefully

1. The use of three vials can effectivety dissolve crystallization (ittakes time to dissolve crystallization);2. The product has great somatosensation after taking it atleast 21 days in the early stage;3. Elevated uric acid or gout recurrence and site changes arenormal in the early stage of taking this product;4. Try not to drink alcohol or drink less 15 days before takingthis product;

5. This product certainly has significant effect on gout,crystallization and hyperuricemia;

Section 50565-1 (50565-1)

Keep out of reach of children

Section 51727-6 (51727-6)

This product has a significanteffect on gout, crystal deposits,and hyperuricemia;

elt has an auxiliary effectof mitigating kidney stonesand bladder stones

Section 51945-4 (51945-4)

Section 55105-1 (55105-1)

This product has a significanteffect on gout, crystal deposits,and hyperuricemia; elt has an auxiliary effectof mitigating kidney stonesand bladder stones

Section 55106-9 (55106-9)

MEDICAGO SATIVA WHOLE 20.00%

CHICORY ROOT 23.00%

GLUCOSAMINE HYDROCHLORIDE 10.00%

BUCKWHEAT 7.00%

TEA LEAF 5.00%

MORUS ALBA LEAF 13.00%

LICORICE 0.20%

FU LING 2.00%

COIX LACRYMA-JOBI SEED 8.00%

Section 60561-8 (60561-8)

Do not use if seal is broken.

Do not eat freshness packet enclosed.

Keep out of direct sunlight, high temperature, and humidity.

Store in a cool, dry place.


Advanced Ingredient Data


Raw Label Data

All Sections (JSON)